Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

Publication | Open Access

DOI Full Paper Access

191

Citations

References

2015

Year

Chiara Cremolini, Fotios Loupakis, C. Antoniotti, Sara Lonardi, Gianluca Masi, Lisa Salvatore, Enrico Cortesi, Giovanni Tomasello, Rosella Spadi, Alberto Zaniboni,

Annals of Oncology

Early Tumor ShrinkageMedicineColorectal CancerPathologyNord OvestCancer TreatmentFirst-line ChemotherapyOncologyRadiation Oncology